Medeze Group Public Company Limited Stock Price

SET:MEDEZE Community·฿6.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Create a narrative

MEDEZE Share Price Performance

฿0

-7.90 (-100.00%)

฿0

-7.90 (-100.00%)

฿0

Thu, 20 Nov 25

Share Pricen/a

MEDEZE Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk

1 Reward

View Full Analysis

Medeze Group Public Company Limited Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.24
: 77.02%
: 31.26%
: 0%

View Full Analysis

About MEDEZE

Founded: 2010
Employees: n/a
CEO: Veerapol Khemarangsan
WebsiteView website: www.medezegroup.com

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition, the company sells dietary supplements, cosmetics, and dermo cosmetics. The company was founded in 2010 and is based in Nakhon Pathom, Thailand.